In a multicenter,randomized clinical trial, ex-prisoners who received six monthly injections of naltrexone–a long-acting medication that blocks opioid receptors in the brain–were significantly less likely to resume opioid use than those who received counseling and referrals to community treatment centers without naltrexone. The study was published online nowadays in novel England Journal of Medicine. [...]
Source: psypost.org